NCT06124131Completed
Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening
Source: ClinicalTrials.gov · Last updated 4 May 2025
Brief summary (registry, in English)
The goal of this pilot clinical trial is to determine feasibility and explore whether financial incentives paid to primary care patients for completing colorectal cancer screening increase completion of colorectal cancer screening. The main questions it aims to answer are: * Do patient financial incentives for completing colorectal cancer screening increase screening completion? * Does a patient financial incentive for colorectal cancer screening offered alongside patient financial incentives for COVID-19 and flu shots increase completion of those shots? Participants who are due for colorectal cancer screening will receive telephone outreach from primary care staff who will offer a stool-based colorectal cancer screening. Participants will be randomly assigned to either Group 1 or Group 2. Group 1 participants will be offered financial incentives for completing COVID-19 and flu shots within 2 months of enrollment. Group 2 participants will be offered financial incentives for completing a COVID-19 shot, a flu shot, and colorectal cancer screening within 2 months of enrollment. Researchers will compare to see if completion of a COVID-19 shot, a flu shot, and colorectal cancer screening is different between the two groups.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 50 (actual)
- First submitted
- 3 Nov 2023
- Start date
- 11 Nov 2023
- Primary completion date
- 25 Mar 2024
- Lead sponsor
- Tulane University
- Diseases
- Colorectal cancer
- NCT number
- NCT06124131
What you commit to
- Study type: Interventional
- Participants enrolled: 50
- From 11 Nov 2023 to the primary completion date, 25 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Currently participating in another clinical trial or research study on colorectal cancer screening
Other
- Unable or unwilling to give informed consent
Who the study is looking for
- Age 45 to 75
- Receive care at participating primary care clinic
- Due for colorectal cancer screening
- Ability to understand and speak English
Age in the registry: 45 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tulane University School of Medicine Coordinator of this site? Confirm its status | New Orleans | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.